The Impact of Dementia on Diabetes Control: An Evaluation of HbA1c Trajectories and Care Outcomes in Linked Primary and Specialist Care Data

被引:2
|
作者
Gungabissoon, Usha [1 ,2 ]
Broadbent, Matthew [3 ]
Perera, Gayan
Ashworth, Mark [4 ]
Galwey, Nicholas [5 ]
Stewart, Robert [3 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neuroscience IoPPN, London, England
[2] GlaxoSmithKline GSK R&D, Epidemiology Value Evidence & Outcomes Global Med, London, England
[3] South London & Maudsley NHS Fdn Trust, London, England
[4] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England
[5] Res Stat GSK R&D, London, England
关键词
Dementia; ambulatory care sensitive condition; diabetes; HbA(1c); ALL-CAUSE MORTALITY; COGNITIVE IMPAIRMENT; OLDER-ADULTS; TYPE-2; HBA1C; MELLITUS; RISK; HYPOGLYCEMIA; ASSOCIATIONS; DISEASE;
D O I
10.1016/j.jamda.2022.04.045
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Diabetes self-care may become increasingly challenging as cognition declines. We sought to characterize glycated hemoglobin A(1c) (HbA(1c)) trajectories, markers of diabetes-related management, health care utilization, and mortality in people with preexisting type 2 diabetes (T2D) with and without dementia and based on the extent of cognitive impairment at the time of dementia diagnosis. Design: Retrospective matched cohort study. Setting and Participants: Using a linkage between a primary care (Lambeth DataNet) and a secondary mental healthcare database, up to 5 individuals aged >= 65 y with preexisting T2D without dementia were matched to each individual with dementia based on age, sex, and general practice. Methods: Comparisons were made for HbA(1c) trajectories (linear mixed effects models), markers of diabetes-related management and severity at dementia diagnosis (logistic regression), mortality (Cox regression), and health care utilization (multilevel mixed effects binomial regression). Results: In 725 incident dementia and 3154 matched comparators, HbA(1c) trajectories differed by dementia status; HbA(1c) increased over time for mild dementia and non-dementia, but the increase was greater in the mild dementia group; for those with moderate-severe dementia, HbA(1c) decreased over time. Despite individuals with dementia having increased health care utilization around the time of dementia diagnosis, they were less likely to have had routine diabetes-related management. Patients with dementia had a higher prevalence of macrovascular complications and diabetes foot morbidity at dementia diagnosis and a higher mortality risk than those without dementia; these relationships were most marked in those with moderate-severe dementia. Conclusions and Implications: Our study has highlighted important differences in the monitoring, management, and control of diabetes in people with dementia. The effects of frailty and the extent of cognitive impairment on the ability to self-manage diabetes and on glycemic control may need to be considered in treatment guidelines and by primary care. (C) 2022 The Authors. Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:1555 / +
页数:13
相关论文
共 50 条
  • [1] The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community-based Integrated Care System 8-items (DASC-8): A cross-sectional study of elderly patients with diabetes
    Miya, Aika
    Nakamura, Akinobu
    Yokota, Isao
    Cho, Kyu Yong
    Kameda, Hiraku
    Nomoto, Hiroshi
    Takase, Takahiro
    Omori, Kazuno
    Ono, Mayuko
    Nagai, So
    Taneda, Shinji
    Miyoshi, Hideaki
    Atsumi, Tatsuya
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2022, 22 (08) : 560 - 567
  • [2] HbA1c variability associated with dementia risk in people with type 2 diabetes
    Moran, Chris
    Whitmer, Rachel A.
    Dove, Zoe
    Lacy, Mary E.
    Soh, Yenee
    Tsai, Ai-Lin
    Quesenberry, Charles P.
    Karter, Andrew J.
    Adams, Alyce S.
    Gilsanz, Paola
    ALZHEIMERS & DEMENTIA, 2024, 20 (08) : 5561 - 5569
  • [3] Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care
    Arnardottir, Elin
    Sigurdardottir, Arun K.
    Graue, Marit
    Kolltveit, Beate-Christin Hope
    Skinner, Timothy
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [4] Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network
    Berkowitz, S. A.
    Atlas, S. J.
    Grant, R. W.
    Wexler, D. J.
    DIABETIC MEDICINE, 2014, 31 (07) : 839 - 846
  • [5] Elevated HbA1c is Associated with Increased Risk of Incident Dementia in Primary Care Patients
    Ramirez, Alfredo
    Wolfsgruber, Steffen
    Lange, Carolin
    Kaduszkiewicz, Hanna
    Weyerer, Siegfried
    Werle, Jochen
    Pentzek, Michael
    Fuchs, Angela
    Riedel-Heller, Steffi G.
    Luck, Tobias
    Moesch, Edelgard
    Bickel, Horst
    Wiese, Birgitt
    Prokein, Jana
    Koenig, Hans-Helmut
    Brettschneider, Christian
    Breteler, Monique M.
    Maier, Wolfgang
    Jessen, Frank
    Scherer, Martin
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (04) : 1203 - 1212
  • [6] Evaluation of a HbA1c point-of-care analyzer
    Menendez-Valladares, Paloma
    Fernandez-Riejos, Patricia
    Sanchez-Mora, Catalina
    Perez-Perez, Antonio
    Sanchez-Margalet, Victor
    Gonzalez-Rodriguez, Concepcion
    CLINICAL BIOCHEMISTRY, 2015, 48 (10-11) : 686 - 689
  • [7] Point of Care Testing for HbA1c in Primary Care-cobas b 101 Instrument Evaluation
    Tirimacco, Rosy
    Cowley, Penelope J.
    Simpson, Paul A.
    Siew, Limei
    St John, Andrew
    Tideman, Philip A.
    POINT OF CARE, 2016, 15 (04): : 129 - 131
  • [8] Distinct HbA1c trajectories in a type 2 diabetes cohort
    Walraven, Iris
    Mast, M. Ruth
    Hoekstra, Trynke
    Jansen, A. P. Danielle
    van der Heijden, Amber A. W. A.
    Rauh, Simone P.
    Rutters, Femke
    van't Riet, Esther
    Elders, Petra J. M.
    Moll, Annette C.
    Polak, Bettine C. P.
    Dekker, Jacqueline M.
    Nijpels, Giel
    ACTA DIABETOLOGICA, 2015, 52 (02) : 267 - 275
  • [9] Do people with diabetes understand their clinical marker of long-term glycemic control (HbA1c levels) and does this predict diabetes self-care behaviours and HbA1c?
    Beard, Emma
    Clark, Marie
    Hurel, Steve
    Cooke, Debbie
    PATIENT EDUCATION AND COUNSELING, 2010, 80 (02) : 227 - 232
  • [10] Variation in Point-of-Care Testing of HbA1c in Diabetes Care in General Practice
    Kristensen, Troels
    Waldorff, Frans Boch
    Nexoe, Jorgen
    Skovsgaard, Christian Volmar
    Olsen, Kim Rose
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2017, 14 (11):